Results 31 to 40 of about 21,986 (186)
PLoS ONE, 2017 BackgroundImmunologic tests such as the tuberculin skin test (TST) and QuantiFERON®-TB Gold In-Tube test (QFT-GIT) are designed to detect Mycobacterium tuberculosis infection, both latent M.
Jason M Lempp +6 more
doaj +1 more source
Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age. [PDF]
PLoS ONE, 2016 Currently, there are two types of interferon-gamma release assays (IGRAs) in use for the detection of tuberculosis (TB) infection, the QuantiFERON-TB Gold In-Tube test (GFT-GIT) and T-SPOT.TB.
Won Bae +10 more
doaj +1 more source
Scientific Reports, 2022 This study aimed to find significant factors associated with tuberculosis (TB) infection and disease development. The participants were from National Health and Nutrition Examination Survey (NHANES) and National Death Index (NDI).
Hai-bo Hua, Hui-jie Wang
doaj +1 more source
Infectious Diseases, 2017 Background: Interferon (IFN)-γ-releasing assay for diagnosing tuberculosis (TB) has shown promise; however, there are only a few reports on usefulness of the QuantiFERON-TB Gold In-Tube test (QFT-GIT) for diagnosing TB vertebral osteomyelitis. Methods: All patients presenting at a tertiary hospital between January 2010 and July 2016 with suspected TB ...
Sungim Choi +13 more
openaire +2 more sources
PLoS ONE, 2020 BackgroundWe investigated changes in the interferon-γ levels before and after treatment of latent tuberculosis infection (LTBI) using QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON-TB Gold In-Tube (QFT-GIT) assays.
Ock-Hwa Kim +6 more
doaj +1 more source
, 2023 Additional file 1: Table S1. PRISMA checklist. Table S2. Search strategy. Table S2. Search strategy. Table S3. Inclusion and partial exclusion for patients with active TB. Table S4. Inclusion and partial exclusion for populations with very low risk of TB exposure. Table S5. Inclusion and partial exclusion for high-risk populations.
Zhang, Yu +8 more
openaire +1 more source
PLoS ONE, 2018 This study aims to compare the latent tuberculosis infection (LTBI) screening strategy of interferon-gamma release assay (IGRA)-alone and in combination with tuberculin skin tests (TSTs) before the initiation of tumor necrosis factor (TNF) inhibitor ...
Dae Hyun Jeong +8 more
doaj +1 more source
Diagnostic values of the QuantiFERON-TB Gold In-tube assay carried out in China for diagnosing pulmonary tuberculosis. [PDF]
PLoS ONE, 2015 BACKGROUND:Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC).
Hui Xia +7 more
doaj +1 more source
Retrospective Performance Analyses of over Two Million U.S. QuantiFERON Blood Sample Results
Microbiology Spectrum, 2021 Both the QuantiFERON-TB Gold Plus (QFT-Plus) and the QuantiFERON-TB Gold In-Tube (QFT-GIT) tests are interferon gamma (IFN-γ) release assays (IGRAs) intended to detect in vitro cell-mediated immune responses to Mycobacterium tuberculosis antigens.
Caixia Bi +6 more
doaj +1 more source
QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection [PDF]
The Korean Journal of Internal Medicine, 2020 Background/Aims QuantiFERON-TB Gold PLUS (QFT-PLUS) was developed as a new version of the interferon-γ (IFN-γ) release assay that contains an extra antigen tube to elicit a CD8+ T-cell response in addition to a CD4+ T-cell response.
Soo Han Kim, Kyung-Wook Jo, Tae Sun Shim
doaj +1 more source